CARM

Carisma Therapeutics, Inc. · NASDAQ

Sector Health Technology
Industry Biotechnology
Website carismatx.com
Employees(FY) -
ISIN US14216R1014

Performance

-6.62%

1W

-17.06%

1M

-38.7%

3M

-44.05%

6M

-51.88%

YTD

-71.05%

1Y

Profile

Carisma Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing immunotherapies to treat cancer and other serious diseases. The company's clinical and pre-clinical programs include CT-0508 and CT-0525 targeting HER2 overexpressing tumors; and CT-1119, a CAR-Monocyte for mesothelin overexpressing solid tumors. The company was formerly known as CARMA Therapeutics Inc. and changed its name to Carisma Therapeutics, Inc. in May 2017. The company was founded in 2016 and is headquartered in Philadelphia, Pennsylvania.

Advanced Technical Analysis

Technical Analysis of CARM 2024-05-10

Overview:

In analyzing the technical indicators for CARM stock over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key indicators, we aim to offer valuable insights and predictions for potenti...

See more ...

Recent News & Updates

2024-05-15 19:30
Carisma Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial of CT-0525, a Novel HER2-Targeting CAR-Monocyte(Prnewswire)
2024-05-09 01:54
CARM Stock Earnings: CARISMA Therapeutics Misses EPS, Misses Revenue for Q1 2024(Investorplace)
2024-05-08 20:35
Carisma Therapeutics Inc. (CARM) Reports Q1 Loss, Misses Revenue Estimates(Zacks)
2024-05-08 19:30
Carisma Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights(Prnewswire)
2024-05-07 19:30
Carisma Therapeutics Presents Preclinical Proof of Concept Data Demonstrating the Anti-Fibrotic Potential of Engineered Macrophages at ASGCT 2024(Prnewswire)
2024-05-05 19:30
Carisma Therapeutics to Participate in The Citizens JMP Life Sciences Conference(Prnewswire)
2024-05-01 22:01
Carisma Therapeutics Inc. (CARM) May Report Negative Earnings: Know the Trend Ahead of Q1 Release(Zacks)
2024-05-01 19:30
Carisma Therapeutics Appoints Dr. Eugene P. Kennedy as Chief Medical Officer(Prnewswire)
2024-04-24 05:05
Carisma Therapeutics Announces Upcoming Presentation at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting(Prnewswire)
2024-04-22 04:35
Carisma Therapeutics to Present New Data at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting(Prnewswire)
2024-04-03 21:55
Here's Why CARISMA THERAP (CARM) Is a Great 'Buy the Bottom' Stock Now(Zacks)
2024-04-02 19:00
Carisma Therapeutics to Present at Upcoming Conferences(Prnewswire)
2024-04-01 01:53
CARM Stock Earnings: CARISMA Therapeutics Beats EPS, Beats Revenue for Q4 2023(Investorplace)
2024-03-31 20:35
Carisma Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results(Prnewswire)
2024-03-31 19:00
Carisma Therapeutics Announces Changes to its Board of Directors(Prnewswire)
2024-03-21 05:00
Carisma Announces Upcoming Presentations at the American Association for Cancer Research (AACR) Annual Meeting(Prnewswire)
2024-02-27 18:30
Carisma Therapeutics to Participate in TD Cowen's 44th Annual Health Care Conference(Prnewswire)
2023-12-20 18:00
Carisma Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference(Prnewswire)
2023-12-13 18:00
First In Vivo CAR-M Lead Candidate Nominated Under Carisma-Moderna Collaboration(Prnewswire)
2023-11-27 18:00
Carisma Therapeutics Announces FDA Clearance of IND Application for CT-0525, a Novel HER2-Targeting CAR-Monocyte(Prnewswire)
2023-11-21 18:30
Carisma Therapeutics to Participate in Evercore ISI HealthCONx Conference(Prnewswire)
2023-11-08 18:30
Carisma Therapeutics Reports Third Quarter 2023 Financial Results and Recent Business Highlights(Prnewswire)
2023-10-30 21:25
Carisma Presents Pre-Clinical Proof of Concept for in vivo CAR-M using mRNA platform in collaboration with Moderna at SITC(Prnewswire)
2023-10-24 21:11
Carisma to Present First Results From in vivo CAR-M Collaboration with Moderna at SITC 2023(Prnewswire)
2023-10-12 02:52
3 Top Under-$5 Stocks for Strong Gains and Positive Outlook(Yahoo Finance)
2023-09-04 20:30
Carisma Therapeutics to Present at Upcoming Investor Conferences(Yahoo Finance)
2023-08-31 20:30
Carisma Announces Latest Data from Phase 1 Clinical Trial of CT-0508 at 8th Annual CAR-TCR Summit(Yahoo Finance)
2023-08-23 20:30
Carisma Therapeutics to Present at Upcoming Healthcare Industry Conferences in September 2023(Yahoo Finance)
2023-08-22 21:55
Wall Street Analysts Predict a 48.37% Upside in Carisma Therapeutics Inc. (CARM): Here's What You Should Know(Yahoo Finance)
2023-08-12 20:07
Carisma Therapeutics Second Quarter 2023 Earnings: Beats Expectations(Yahoo Finance)

Page 1 of 2

previousnext